ArthroTAK Tendon Anchor Kit
ArthroTAK, LLC · Decision date Sep 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the ArthroTAK Tendon Anchor Kit, a 510(k) submitted by ArthroTAK, LLC of Missoula, Montana. The decision date is 02 September 2026; the application was received 07 August 2026 under number K262809. The device falls under regulation 888.3040, classification name Fastener, Fixation, Nondegradable, Soft Tissue, product code MBI, with an orthopedic medical specialty and orthopedic review panel. A SESE decision is a clearance, not a PMA approval.
The public record lists the summary type as Special, states the submission was not reviewed by a third party, and records no combination product and no authorized predetermined change control plan. The record does not identify a predicate device, describe the kit's components or materials, or give indications, so the basis for equivalence and the cleared scope remain unknown from this page. The listed correspondent is Greenfield Consulting, LLC.
No clinical or performance data are presented in the available fields, and no conclusion about safety or effectiveness should be drawn from the clearance alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262809
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ArthroTAK, LLC
- Product code
- MBI
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.
- Applicant
- ArthroTAK, LLC
- Product code
- MBI
- FDA device class
- 2
FDA decision timeline
K262809 received
Application receipt date recorded by FDA.
K262809 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Arthrex FiberButtonK263477 | ARTHREX, INC. | 510(k) clearance | Oct 27, 2026 | FDA |
| Smith & Nephew, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
TeKBrace Knotless AnchorK263352 | TheraMicro | 510(k) clearance | Oct 21, 2026 | FDA |
| Anika Therapeutics, Inc. | 510(k) clearance | Sep 17, 2026 | FDA | |
| Aevumed, Inc. | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ArthroTAK, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Missoula, MT
Sources and methodology
- Original FDA record: K262809
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



